Journey Advisory Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,135
Closed -$375K 268
2025
Q4
$375K Buy
+1,135
New +$385K 0.03% 216
2025
Q2
Sell
-824
Closed -$431K 294
2025
Q1
$431K Sell
824
-8,310
-91% -$4.25M 0.04% 205
2024
Q4
$4.65M Hold
9,134
0.56% 54
2024
Q3
$4.65M Hold
9,134
0.56% 54
2024
Q2
$4.65M Sell
9,134
-60
-0.7% -$29.4K 0.56% 54
2024
Q1
$4.55M Buy
9,194
+212
+2% +$108K 0.56% 50
2023
Q4
$4.73M Buy
8,982
+28
+0.3% +$14.9K 0.64% 43
2023
Q3
$4.51M Buy
8,954
+269
+3% +$132K 0.67% 44
2023
Q2
$4.17M Buy
8,685
+561
+7% +$274K 0.62% 50
2023
Q1
$3.84M Buy
8,124
+1,647
+25% +$795K 0.6% 48
2022
Q4
$3.43M Buy
6,477
+206
+3% +$109K 0.85% 32
2022
Q3
$3.17M Buy
6,271
+1,140
+22% +$599K 0.81% 28
2022
Q2
$2.75M Buy
5,131
+912
+22% +$458K 0.63% 41
2022
Q1
$2.15M Buy
4,219
+533
+14% +$257K 0.54% 49
2021
Q4
$1.85M Buy
3,686
+381
+12% +$172K 0.51% 50
2021
Q3
$1.29M Buy
3,305
+1,000
+43% +$414K 0.42% 59
2021
Q2
$923K Buy
2,305
+383
+20% +$153K 0.29% 75
2021
Q1
$715K Buy
1,922
+292
+18% +$101K 0.25% 90
2020
Q4
$572K Buy
+1,630
New +$546K 0.21% 93

Other funds holding UNH

Journey Advisory Group's UNH Position: Q1 2026 in Review

Journey Advisory Group sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 1,135 shares — an estimated $375K sold.

Journey Advisory Group first reported a position in UNH in Q4 2020 and held it in 19 quarters. The position peaked at $4.73M in Q4 2023. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Journey Advisory Group reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • Journey Advisory Group sold 1,135 UnitedHealth shares in Q1 2026, an estimated $375K.
  • Journey Advisory Group first reported a position in UnitedHealth in Q4 2020 and held it in 19 quarters.
  • Journey Advisory Group's UnitedHealth position peaked at $4.73M in Q4 2023.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Journey Advisory Group's 13F filing for Q1 2026, filed 5 May 2026.